The current investor indifference towards the small price fluctuations of SBI Pharma could raise concerns from investors as the entity closed today at a share price of 0.0 on 0 in volume. The fund administrators and managers did not add any value to SBI Pharma Reg investors in May. However, most investors can still diversify their portfolios with SBI Pharma to hedge your portfolio against high-volatility market scenarios. The fund standard deviation of daily returns for 30 days (very short) investing horizon is currently 0.0. The very small Fund volatility is a good signal to investors with longer term investment horizons. This diagnostics interface makes it easy to digest most current publicly released information about SBI Pharma as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis SBI Pharma price relationship with some important fundamental indicators such as market cap and management efficiency. See also Investing Opportunities.
SBI Pharma Note
The fund retains about 7.41% of assets under management (AUM) in cash.
SBI Pharma Reg Alerts
|SBI Pharma Reg is not yet fully synchronised with the market data|
|SBI Pharma Reg has some characteristics of a very speculative penny stock|
|The fund retains about 7.41% of its assets under management (AUM) in cash|
Top Fund Constituents
|Alkem Laboratories Limited||(0.0286)||(1.69)|
|Strides Shasun Limited||(0.0162)||(4.41)|
SBI Pharma Technical and Predictive Indicators
Use basic forecasting models to generate price predictions and determine price momentum
|All Next||Launch Module|
See also Investing Opportunities. Please also try Cryptocurrency Arbitrage module to find pairs of digital assets on multiple exchanges that are traded at a risk free arbitrage.